These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34058900)

  • 1. Transcranial Magnetic Stimulation in Succinic Semialdehyde Dehydrogenase Deficiency: A Measure of Maturational Trajectory of Cortical Excitability.
    Tsuboyama M; Liu J; Kaye H; DiBacco M; Pearl PL; Rotenberg A
    J Child Neurol; 2021 Nov; 36(13-14):1169-1176. PubMed ID: 34058900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GABAB-ergic motor cortex dysfunction in SSADH deficiency.
    Reis J; Cohen LG; Pearl PL; Fritsch B; Jung NH; Dustin I; Theodore WH
    Neurology; 2012 Jul; 79(1):47-54. PubMed ID: 22722631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delays in latencies of median-nerve evoked magnetic fields in patients with succinic semialdehyde dehydrogenase deficiency.
    Matsubara T; Khan S; Sundaram P; Stufflebeam S; Aygun D; DiBacco M; Roullet JB; Pearl PL; Okada Y
    Clin Neurophysiol; 2024 May; 161():52-58. PubMed ID: 38447494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speech Motor Function and Auditory Perception in Succinic Semialdehyde Dehydrogenase Deficiency: Toward Pre-Supplementary Motor Area (SMA) and SMA-Proper Dysfunctions.
    Ahmadi ZZ; DiBacco ML; Pearl PL
    J Child Neurol; 2021 Nov; 36(13-14):1210-1217. PubMed ID: 33757330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular outcomes from the 5-Year natural history study of SSADH Deficiency, a model metabolic neurodevelopmental disorder.
    Tokatly Latzer I; Roullet JB; Afshar-Saber W; Lee HHC; Bertoldi M; McGinty GE; DiBacco ML; Arning E; Tsuboyama M; Rotenberg A; Opladen T; Jeltsch K; García-Cazorla À; Juliá-Palacios N; Gibson KM; Sahin M; Pearl PL
    J Neurodev Disord; 2024 Apr; 16(1):21. PubMed ID: 38658850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency.
    Tokatly Latzer I; Bertoldi M; DiBacco ML; Arning E; Tsuboyama M; MacMullin P; Sachee D; Rotenberg A; Lee HHC; Aygun D; Opladen T; Jeltsch K; García-Cazorla À; Roullet JB; Gibson KM; Pearl PL
    Epilepsia; 2023 Jun; 64(6):1516-1526. PubMed ID: 36961285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Succinic semialdehyde dehydrogenase deficiency (SSADHD): Pathophysiological complexity and multifactorial trait associations in a rare monogenic disorder of GABA metabolism.
    Malaspina P; Roullet JB; Pearl PL; Ainslie GR; Vogel KR; Gibson KM
    Neurochem Int; 2016 Oct; 99():72-84. PubMed ID: 27311541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Randomized Controlled Trial of SGS-742, a γ-aminobutyric acid B (GABA-B) Receptor Antagonist, for Succinic Semialdehyde Dehydrogenase Deficiency.
    Schreiber JM; Wiggs E; Cuento R; Norato G; Dustin IH; Rolinski R; Austermuehle A; Zhou X; Inati SK; Gibson KM; Pearl PL; Theodore WH
    J Child Neurol; 2021 Nov; 36(13-14):1189-1199. PubMed ID: 34015244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glymphatic dysfunction coincides with lower GABA levels and sleep disturbances in succinic semialdehyde dehydrogenase deficiency.
    Tokatly Latzer I; Yang E; Afacan O; Arning E; Rotenberg A; Lee HHC; Roullet JB; Pearl PL
    J Sleep Res; 2024 Aug; 33(4):e14105. PubMed ID: 38148273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GABAA Receptor Availability in Relation to Cortical Excitability in Depressed and Healthy: A Positron Emission Tomography and Transcranial Magnetic Stimulation Study.
    Steinholtz L; Thörnblom E; Bodén R; Wall A; Axelson HW; Lubberink M; Fällmar D; Persson J
    Neuropsychobiology; 2024; 83(1):17-27. PubMed ID: 38151012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical excitability measured with transcranial magnetic stimulation in children with epilepsy before and after antiepileptic drugs.
    Andreasson AC; Sigurdsson GV; Pegenius G; Thordstein M; Hallböök T
    Dev Med Child Neurol; 2020 Jul; 62(7):793-798. PubMed ID: 32064586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Quality-of-Life Survey for Patients With Succinic Semialdehyde Dehydrogenase Deficiency, a Rare Disorder of GABA Metabolism.
    Bose M; Roullet JB; Gibson KM; Rizzo WB; Mansur HM; McConnell A; Hoffman CA; DiBacco ML; Pearl PL
    J Child Neurol; 2021 Nov; 36(13-14):1223-1230. PubMed ID: 34463169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity.
    Lee HHC; Pearl PL; Rotenberg A
    J Child Neurol; 2021 Nov; 36(13-14):1200-1209. PubMed ID: 33624531
    [TBL] [